Hannelore Ehrenreich

Author PubWeight™ 86.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A 2008 3.74
2 Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 2014 2.36
3 Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008 2.27
4 Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 2011 2.21
5 Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke 2013 2.07
6 Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry 2014 2.01
7 Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci 2010 1.59
8 Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004 1.44
9 Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 2008 1.40
10 Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009 1.36
11 The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol 2006 1.23
12 Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 2005 1.21
13 Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 2010 1.21
14 Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 2010 1.17
15 Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol 2010 1.16
16 Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 2008 1.14
17 The structure and usage of female and male mouse ultrasonic vocalizations reveal only minor differences. PLoS One 2012 1.13
18 Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. Nat Clin Pract Neurol 2007 1.12
19 The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 2010 1.10
20 Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology 2004 1.09
21 Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. J Cell Sci 2009 1.05
22 Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 2004 1.04
23 Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res 2006 1.04
24 Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia 2009 1.02
25 Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul Disord 2008 1.01
26 In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab 2005 1.01
27 A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med 2011 1.00
28 Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res 2012 0.99
29 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci 2012 0.99
30 Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003 0.95
31 ETB receptor deficiency causes salt-sensitive hypertension. J Mol Med (Berl) 2002 0.95
32 Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatr Serv 2006 0.93
33 Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) 2005 0.93
34 A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 2012 0.92
35 Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin 2004 0.92
36 Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol 2006 0.92
37 Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Pathol 2013 0.91
38 Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol 2013 0.91
39 Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res 2004 0.90
40 Erythropoietin: not just about erythropoiesis. Lancet 2010 0.90
41 Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behav Brain Res 2009 0.89
42 Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 2006 0.89
43 Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) 2011 0.89
44 Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 2003 0.87
45 A pilot study on the oral conditions of severely alcohol addicted persons. J Contemp Dent Pract 2003 0.86
46 Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol 2009 0.86
47 Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol 2011 0.85
48 Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 2010 0.85
49 The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler 2008 0.85
50 Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol Med 2012 0.85
51 Circadian modulation of GABA-mediated cortical inhibition. Cereb Cortex 2011 0.84
52 Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 2010 0.84
53 Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cell Signal 2007 0.83
54 Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett 2006 0.83
55 Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry 2011 0.83
56 Mild expression differences of MECP2 influencing aggressive social behavior. EMBO Mol Med 2014 0.82
57 Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury. Glia 2013 0.82
58 Monogenic heritable autism gene neuroligin impacts Drosophila social behaviour. Behav Brain Res 2013 0.82
59 Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord 2008 0.82
60 Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Mol Med 2012 0.81
61 Mast cells and endothelin-1: a life-saving biological liaison? Trends Immunol 2005 0.81
62 Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients. J Pineal Res 2002 0.81
63 A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011 0.81
64 Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo. Brain Res 2002 0.81
65 Chronic psychosocial stress in the absence of social support induces pathological pre-pulse inhibition in mice. Behav Brain Res 2009 0.80
66 Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. Alcohol Alcohol 2003 0.80
67 Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochem Res 2006 0.80
68 Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Mol Cancer Ther 2009 0.79
69 Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism. Dialogues Clin Neurosci 2007 0.79
70 Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans. Mol Med 2013 0.79
71 Effect of endothelin-1 on astrocytic protein content. Glia 2003 0.79
72 Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med 2008 0.79
73 Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics. Alcohol Alcohol 2006 0.78
74 Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 2010 0.78
75 Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys 2008 0.78
76 A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. Bipolar Disord 2014 0.78
77 Pre-embedding immunogold labeling of TUNEL stain enables evaluation of DNA strand breaks and ultrastructural alterations in individual cells of neuronal tissue. Acta Neuropathol 2002 0.78
78 Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcohol Clin Exp Res 2011 0.78
79 Fast cerebellar reflex circuitry requires synaptic vesicle priming by munc13-3. Cerebellum 2015 0.77
80 Effects of cerebrovascular challenges on plasma endothelin. Neurosci Res 2002 0.77
81 Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 2004 0.77
82 Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes. J Psychiatr Res 2008 0.77
83 Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry 2013 0.76
84 Dr Miskowiak and colleagues reply. J Clin Psychiatry 2015 0.75
85 Therapist rotation--a new element in the outpatient treatment of alcoholism. Subst Use Misuse 2004 0.75
86 The approximate planimetric method: a simple, rapid and reliable method for estimation of lesion size in acute ischemic stroke. Neuroradiology 2003 0.75
87 Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? Neurochem Res 2005 0.75
88 [Oral condition of abstaining alcoholics. A case-control study]. Schweiz Monatsschr Zahnmed 2003 0.75